The Clinical Efficacy And Safety Of Tuerp And Tkrp For The Treatment Of High-risk Bph Patients

Background and ObjectiveTo assess the clinical efficacy and safety of transurethral enucleativeresection of prostate(TUERP) and transurethral plasma kinetic resection ofthe prostate（TKRP） for treatment of high risk patients with benignprostatic hyperplasia.MethodsThe surgical procedures of sixty-seven cases with high-risk BPH wereanalyzed retrospectively.The operation time, bleeding, resected tissueweight， the mean bladder irrigating time,complications, internationalprostate symptom score (IPSS),quality of life score (QOL),maximum flowrate(Qmax),and postvoid residua(PVR) were compared.Results31cases and36cases were performed by the methods of TUERP andPKRP respectively.There was no significant difference of preoperativefactors between the two groups(P>0.05).The operation time, bleeding, themean bladder irrigating time, and hospital stay were significant shorter in PUERP than in TKRP(P<0.05).The prostate resection rate in TUERP washigher than in TKRP (P <0.05). IPSS QOL Qmax and RVR were improvedin the two groups after the operation (P<0.01),and there showed nosignificant difference between the two groups(P>0.05).ConclusionThere is no difference in efficiency between two groups,but TUERP hasadvantages in operation time,bleeding, hospital stay, the mean bladderirrigating time and complications...